DNMT3A and myelodysplastic syndrome: DNMT3A mutations, that account for the most frequent genetic aberrations in the aging hematopoietic system, can also be detected in myeloid neoplasia such as myelodysplastic syndrome (MDS) [84], supporting the concept that the underlying clonal architecture represents a fertile soil for development of hematopoietic cancers.